SOUTH SAN FRANCISCO, Calif. (AP) — MyoKardia Inc. (MYOK) on Thursday reported a fourth-quarter loss of $7.4 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 21 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.
The biopharmaceutical company posted revenue of $5.6 million in the period.
For the year, the company reported that its loss widened to $46 million, or $1.40 per share. Revenue was reported as $22.5 million.
MyoKardia shares have climbed 31 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $54.95, more than quadrupling in the last 12 months.